OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?
Khalid Mehmood, Afrasim Moin, Talib Hussain, et al.
Folia Microbiologica (2021) Vol. 66, Iss. 6, pp. 897-916
Closed Access | Times Cited: 8

Showing 8 citing articles:

Synthesis and Functions of Resistant Starch
Zhanggui Wang, Shu‐Li Wang, Qinhong Xu, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 5, pp. 1131-1144
Open Access | Times Cited: 44

The heart of the matter: How gut microbiota-targeted interventions influence cardiovascular diseases
Mohammad Abavisani, Pourya Tafti, Niloofar Khoshroo, et al.
Pathology - Research and Practice (2025), pp. 155931-155931
Closed Access

Structural changes in the gut virome of patients with atherosclerotic cardiovascular disease
Youshan Li, Jie Ma, Jinxin Meng, et al.
Microbiology Spectrum (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7

The Early Effects of Bariatric Surgery on Cardiac Structure and Function: a Systematic Review and Meta-Analysis
Shanya Huang, Lan Yi, Chunlan Zhang, et al.
Obesity Surgery (2022) Vol. 33, Iss. 2, pp. 453-468
Closed Access | Times Cited: 9

Global research trends and hotspots of fecal microbiota transplantation: A bibliometric and visualization study
Mancai Wang, Xiaofeng Xie, Songbo Zhao, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 8

Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?
Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony T. Olofinnade, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 9, pp. 1355-1368
Closed Access | Times Cited: 2

Roles of gut dysbiosis, anti-proliferative proteins, and post-transcriptional regulation in carcinogenesis
Haruka Sawamura, Kurumi Taniguchi, Yuka Ikeda, et al.
Journal of Translational Genetics and Genomics (2022) Vol. 6, pp. 157-168
Open Access | Times Cited: 2

Page 1

Scroll to top